AYLA Annual EBITDA
-$39.05 M
-$9.46 M-31.95%
31 December 2021
Summary:
As of February 5, 2025, AYLA annual earnings before interest, taxes, depreciation & amortization is -$39.05 million, with the most recent change of -$9.46 million (-31.95%) on December 31, 2021. During the last 3 years, it has fallen by -$30.06 million (-334.56%).AYLA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AYLA Quarterly EBITDA
-$10.04 M
-$2.25 M-28.91%
30 September 2022
Summary:
As of February 5, 2025, AYLA quarterly earnings before interest, taxes, depreciation & amortization is -$10.04 million, with the most recent change of -$2.25 million (-28.91%) on September 30, 2022. Over the past year, it has dropped by -$521.00 thousand (-5.47%).AYLA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AYLA TTM EBITDA
-$37.39 M
-$521.00 K-1.41%
30 September 2022
Summary:
As of February 5, 2025, AYLA TTM earnings before interest, taxes, depreciation & amortization is -$37.39 million, with the most recent change of -$521.00 thousand (-1.41%) on September 30, 2022. Over the past year, it has increased by +$1.25 million (+3.22%).AYLA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AYLA EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -31.9% | -5.5% | +3.2% |
3 y3 years | -334.6% | -103.3% | -112.9% |
5 y5 years | -334.6% | -180.5% | -112.9% |
AYLA EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | +334.6% | +180.5% | +944.5% |
Ayala Pharmaceuticals EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2022 | - | -$10.04 M(+28.9%) | -$37.39 M(+1.4%) |
June 2022 | - | -$7.79 M(-20.7%) | -$36.87 M(-7.2%) |
Mar 2022 | - | -$9.82 M(+0.9%) | -$39.74 M(+1.9%) |
Dec 2021 | -$39.05 M(+31.9%) | -$9.74 M(+2.3%) | -$38.98 M(+0.9%) |
Sept 2021 | - | -$9.52 M(-10.7%) | -$38.64 M(+6.3%) |
June 2021 | - | -$10.66 M(+17.6%) | -$36.35 M(+12.6%) |
Mar 2021 | - | -$9.06 M(-3.6%) | -$32.27 M(+9.0%) |
Dec 2020 | -$29.59 M | -$9.40 M(+29.9%) | -$29.59 M(+16.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2020 | - | -$7.23 M(+10.0%) | -$25.48 M(+9.9%) |
June 2020 | - | -$6.58 M(+3.0%) | -$23.18 M(+13.8%) |
Mar 2020 | - | -$6.39 M(+20.9%) | -$20.37 M(+16.0%) |
Dec 2019 | -$17.56 M(+95.4%) | -$5.28 M(+7.0%) | -$17.56 M(+43.0%) |
Sept 2019 | - | -$4.94 M(+31.3%) | -$12.28 M(+67.3%) |
June 2019 | - | -$3.76 M(+5.0%) | -$7.34 M(+105.0%) |
Mar 2019 | - | -$3.58 M | -$3.58 M |
Dec 2018 | -$8.99 M | - | - |
FAQ
- What is Ayala Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Ayala Pharmaceuticals?
- What is Ayala Pharmaceuticals annual EBITDA year-on-year change?
- What is Ayala Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Ayala Pharmaceuticals?
- What is Ayala Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Ayala Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Ayala Pharmaceuticals?
- What is Ayala Pharmaceuticals TTM EBITDA year-on-year change?
What is Ayala Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of AYLA is -$39.05 M
What is the all time high annual EBITDA for Ayala Pharmaceuticals?
Ayala Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$8.99 M
What is Ayala Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, AYLA annual earnings before interest, taxes, depreciation & amortization has changed by -$9.46 M (-31.95%)
What is Ayala Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of AYLA is -$10.04 M
What is the all time high quarterly EBITDA for Ayala Pharmaceuticals?
Ayala Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$3.58 M
What is Ayala Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, AYLA quarterly earnings before interest, taxes, depreciation & amortization has changed by -$521.00 K (-5.47%)
What is Ayala Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of AYLA is -$37.39 M
What is the all time high TTM EBITDA for Ayala Pharmaceuticals?
Ayala Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$3.58 M
What is Ayala Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, AYLA TTM earnings before interest, taxes, depreciation & amortization has changed by +$1.25 M (+3.22%)